Print the value of index0
Mojdeh Nazari Mojdeh Amini Nazari, Mojie Amini, Mojie Amini Nazari Counterfeiter, Fraud, Illegal Export, Money Laundering Woodland Hills, California
Zosma Ventures, Inc., the parent company of supplement line
Formulated Sciences has announced that they have filed suit against
Mojdeh Amini-Nazari, Hossein Givi, their company Pars Med Kish, their
shipper, American Export Lines, and their manufacturer, Viva
Pharmaceuticals. The suit, filed with the Federal Court, Los Angeles
district, case number CV12-1404 RSWL (FFMx), has already seen strong
action from presiding Judge Ronald Lew. Both a Federal seizure order and
a preliminary injunction have thus far been granted against the
defendants. In the suit, Zosma contends that the defendants willfully
and knowingly infringed upon Zosmas trademark. Further, Zosma alleges
that the defendants manufactured and exported counterfeit goods in such a
manner as to circumvent existing U.S. laws.
With assistance from the United States Marshalls office, the seizure
order was carried out at five different locations across Southern
California. During the raids, documents were uncovered implicating
pharmaceutical and dietary supplement giant, Viva Pharmaceuticals- based
out of British Columbia with an additional facility in Blaine,
Washington. The documents seized leave a paper trail that shows shipment
to the United States from Viva Pharmaceuticals, then from Los Angeles
straight to Iran, via shipper American Export Lines. Further, over 1.2
million units of counterfeit products have apparently been sold, causing
Zosma estimated damages in the tens of millions of dollars. These
documents, discovered the day before the first hearing on the case, were
provided to the Federal Court as additional exhibits to Zosmas lengthy
complaint. The scope of the operation runs deeper than originally
anticipated by Zosma and their counsel, Mark Vega, of Los Angeles based
Libertas Law Group.
From 2003 to 2008, Pars Med Kish was the exclusive distributor of
Zosmas popular Formulated Sciences line of products. In 2009, Amini
and Givi claimed that demand had decreased, and pending orders were
cancelled. In 2010 Zosma was alerted by an agent of the Iranian Ministry
of Health that their product was again on the shelves in Iranian
pharmacies. After an extensive two year investigation Zosma discovered
the extent of Amini and Givis alleged fraudulent activity. According
to documents found during the U.S. Marshall raid, Amini and Givi moved
production of the fish oil product to Canadian pharmaceutical
manufacturer Viva Pharmaceuticals. Additionally, these documents showed
that Amini and Givi represented that they owned the trademark of
Formulated Sciences to Viva, and began to order millions of dollars
worth of the counterfeit product. According to the USPTO website, Amini
and Givi even went so far as to attempt registration of a slightly
altered Formulated Sciences logo (application number 85496890), which
was rejected by the United States Office of Patent and Trademarks.
According to the suit, Zosma believes that the defendants have
knowingly and willfully infringed upon Zosmas trademark and good name
in order to profit on estimated millions of dollars worth of sales of
the counterfeit goods. By moving for a preliminary injunction, Zosma has
effectively stopped Pars Med, Amini, and Givi along with Viva
Pharmaceuticals and American Export Lines- from continuing to ship the
supposed counterfeit products. Furthermore, the Judge granted Zosmas
request to freeze the defendants assets and bank accounts. Although
Viva and Amini both contend that they have nothing to do with the
operation, they are being represented by the same lawyer, Reza Sina of
Sina Law Group, based in Los Angeles, California.